Global Endoscopic Ultrasound Needles Market – Industry Trends and Forecast to 2028

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Endoscopic Ultrasound Needles Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Feb 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 MARKET GUIDE

2.2.4 COMPANY POSITIONING GRID

2.2.5 COMPANY MARKET SHARE ANALYSIS

2.2.6 MULTIVARIATE MODELLING

2.2.7 TOP TO BOTTOM ANALYSIS

2.2.8 STANDARDS OF MEASUREMENT

2.2.9 VENDOR SHARE ANALYSIS

2.2.10 SALES VOLUME

2.2.11 EPIDEMIOLOGY MODELLING

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8 COST ANALYSIS BREAKDOWN

9 TECHNONLOGY ROADMAP

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

11 REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.2.1 CLASS I

11.2.2 CLASS II

11.2.3 CLASS III

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

12 REIMBURSEMENT FRAMEWORK

13 OPPUTUNITY MAP ANALYSIS

14 INSTALLED BASE DATA

15 VALUE CHAIN ANALYSIS

16 HEALTHCARE ECONOMY

16.1 HEALTHCARE EXPENDITURE

16.2 CAPITAL EXPENDITURE

16.3 CAPEX TRENDS

16.4 CAPEX ALLOCATION

16.5 FUNDING SOURCES

16.6 INDUSTRY BENCHMARKS

16.7 GDP RATION IN OVERALL GDP

16.8 HEALTHCARE SYSTEM STRUCTURE

16.9 GOVERNMENT POLICIES

16.1 ECONOMIC DEVELOPMENT

17 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY PRODUCT TYPE

17.1 OVERVIEW

17.2 BIOPSY NEEDLES (EUS-FNB)

17.2.1 BY TYPE

17.2.1.1. STANDARD

17.2.1.2. FLEXIBLE

17.2.2 BY SHEATH SIZE

17.2.2.1. 4.8 FR

17.2.2.2. 7.95 FR

17.2.2.3. 5.2 FR

17.2.3 BY STYLET TIP

17.2.3.1. ROUND

17.2.3.2. BEVELED

17.2.4 BY QUANTITY

17.2.4.1. 1 EACH

17.2.4.2. 5/BOX

17.2.5 BY NEEDLE LENGTH

17.2.5.1. BELOW 2 CM

17.2.5.2. BETWEEN 2CM TO 6CM

17.2.5.3. ABOVE 6 CM

17.2.6 BY USABILITY

17.2.6.1. DISPOSABLE NEEDLE

17.2.6.2. REUSABLE NEEDLE

17.2.7 OTHERS

17.3 ASPIRATION NEEDLES (EUS-FNA)

17.3.1 BY TYPE

17.3.1.1. STANDARD

17.3.1.2. WITH SIDE PORT/HOLE

17.3.2 BY QUANTITY

17.3.2.1. 1 EACH

17.3.2.2. 5/BOX

17.3.3 BY NEEDLE LENGTH

17.3.3.1. BELOW 2 CM

17.3.3.2. BETWEEN 2CM TO 6CM

17.3.3.3. ABOVE 6 CM

17.3.4 BY SHEATH DIAMETER

17.3.4.1. 1.83 MM

17.3.4.2. 1.65 MM

17.3.4.3. 1.52 MM

17.3.4.4. OTHERS

17.3.5 BY WORKING CHANNEL

17.3.5.1. 2.4 MM

17.3.5.2. 2.8 MM

17.3.6 BY STYLET TIP

17.3.6.1. ROUND

17.3.6.2. BEVELED

17.3.7 BY USABILITY

17.3.7.1. DISPOSABLE NEEDLE

17.3.7.2. REUSABLE NEEDLE

17.3.8 OTHERS

18 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY NEEDLE GAUGE

18.1 OVERVIEW

18.2 22GA

18.3 25GA

18.4 19GA

18.5 OTHERS

19 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY MATERIAL

19.1 OVERVIEW

19.2 STAINLESS STEEL

19.3 COBALT-CHROMIUM ALLOY

19.4 NICKEL AND TITANIUM ALLOY

19.5 OTHERS

20 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY SHEATH USABILITY

20.1 OVERVIEW

20.2 DISPOSABLE

20.2.1 MARKET VALUE (USD MILLION)

20.2.2 MARKET VOLUME (UNITS)

20.2.3 AVERAGE SELLING PRICE (USD)

20.3 REUSABLE

20.3.1 MARKET VALUE (USD MILLION)

20.3.2 MARKET VOLUME (UNITS)

20.3.3 AVERAGE SELLING PRICE (USD)

21 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY STERILITY

21.1 OVERVIEW

21.2 STERILE

21.2.1 MARKET VALUE (USD MILLION)

21.2.2 MARKET VOLUME (UNITS)

21.2.3 AVERAGE SELLING PRICE (USD)

21.3 NON STERILE

21.3.1 MARKET VALUE (USD MILLION)

21.3.2 MARKET VOLUME (UNITS)

21.3.3 AVERAGE SELLING PRICE (USD)

22 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY APPLICATION

22.1 OVERVIEW

22.2 ENTERAL NEEDLES

22.2.1 STAINLESS STEEL

22.2.2 COBALT-CHROMIUM ALLOY

22.2.3 NICKEL AND TITANIUM ALLOY

22.2.4 OTHERS

22.3 BRONCHIAL NEEDLES

22.3.1 STAINLESS STEEL

22.3.2 COBALT-CHROMIUM ALLOY

22.3.3 NICKEL AND TITANIUM ALLOY

22.3.4 OTHERS

22.4 OTHERS

23 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY END USER

23.1 OVERVIEW

23.2 HOSPITALS

23.2.1 BY TYPE

23.2.1.1. PUBLIC

23.2.1.2. PRIVATE

23.2.2 BY TIER

23.2.2.1. TIER 1

23.2.2.2. TIER 2

23.2.2.3. TIER 3

23.3 SPECIALTY CLINICS

23.4 DIAGNOSTIC CENTERS

23.5 AMBULATORY SURGICAL CENTERS

23.6 OTHERS

24 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY DISTRIBUTION CHANNEL

24.1 OVERVIEW

24.2 DIRECT TENDER

24.3 RETAIL SALES

24.3.1 ONLINE

24.3.2 OFFLINE

24.4 THIRD PARTY DISTRIBUTION

24.5 OTHERS

25 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY REGION

GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS

REPRESENTED IN THIS CHAPTER BY COUNTRY)

25.1 NORTH AMERICA

25.1.1 U.S.

25.1.2 CANADA

25.1.3 MEXICO

25.2 EUROPE

25.2.1 GERMANY

25.2.2 FRANCE

25.2.3 U.K.

25.2.4 ITALY

25.2.5 SPAIN

25.2.6 RUSSIA

25.2.7 TURKEY

25.2.8 BELGIUM

25.2.9 DENMARK

25.2.10 NETHERLANDS

25.2.11 SWITZERLAND

25.2.12 SWEDEN

25.2.13 POLAND

25.2.14 NORWAY

25.2.15 FINLAND

25.2.16 REST OF EUROPE

25.3 ASIA-PACIFIC

25.3.1 JAPAN

25.3.2 CHINA

25.3.3 SOUTH KOREA

25.3.4 INDIA

25.3.5 AUSTRALIA

25.3.6 NEW ZEALAND

25.3.7 SINGAPORE

25.3.8 THAILAND

25.3.9 MALAYSIA

25.3.10 VIETNAM

25.3.11 TAIWAN

25.3.12 INDONESIA

25.3.13 PHILIPPINES

25.3.14 REST OF ASIA-PACIFIC

25.4 SOUTH AMERICA

25.4.1 BRAZIL

25.4.2 ARGENTINA

25.4.3 REST OF SOUTH AMERICA

25.5 MIDDLE EAST AND AFRICA

25.5.1 SOUTH AFRICA

25.5.2 SAUDI ARABIA

25.5.3 BAHRAIN

25.5.4 UAE

25.5.5 KUWAIT

25.5.6 OMAN

25.5.7 QATAR

25.5.8 EGYPT

25.5.9 ISRAEL

25.5.10 REST OF MIDDLE EAST AND AFRICA

25.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

26 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, SWOT AND DBMR ANALYSIS

27 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, COMPANY LANDSCAPE

27.1 COMPANY SHARE ANALYSIS: GLOBAL

27.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

27.3 COMPANY SHARE ANALYSIS: EUROPE

27.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

27.5 MERGERS & ACQUISITIONS

27.6 NEW PRODUCT DEVELOPMENT & APPROVALS

27.7 EXPANSIONS

27.8 REGULATORY CHANGES

27.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

28 GLOBAL ENDOSCOPIC ULTRASOUND NEEDLES MARKET, COMPANY PROFILE

28.1 BECTON, DICKINSON AND COMPANY (BD)

28.1.1 COMPANY OVERVIEW

28.1.2 REVENUE ANALYSIS

28.1.3 GEOGRAPHIC PRESENCE

28.1.4 PRODUCT PORTFOLIO

28.1.5 RECENT DEVELOPMENTS

28.2 OLYMPUS CORPORATION

28.2.1 COMPANY OVERVIEW

28.2.2 REVENUE ANALYSIS

28.2.3 GEOGRAPHIC PRESENCE

28.2.4 PRODUCT PORTFOLIO

28.2.5 RECENT DEVELOPMENTS

28.3 COOK

28.3.1 COMPANY OVERVIEW

28.3.2 REVENUE ANALYSIS

28.3.3 GEOGRAPHIC PRESENCE

28.3.4 PRODUCT PORTFOLIO

28.3.5 RECENT DEVELOPMENTS

28.4 MEDI-GLOBE GMBH

28.4.1 COMPANY OVERVIEW

28.4.2 REVENUE ANALYSIS

28.4.3 GEOGRAPHIC PRESENCE

28.4.4 PRODUCT PORTFOLIO

28.4.5 RECENT DEVELOPMENTS

28.5 MICRO-TECH ENDOSCOPY

28.5.1 COMPANY OVERVIEW

28.5.2 REVENUE ANALYSIS

28.5.3 GEOGRAPHIC PRESENCE

28.5.4 PRODUCT PORTFOLIO

28.5.5 RECENT DEVELOPMENTS

28.6 CONMED CORPORATION

28.6.1 COMPANY OVERVIEW

28.6.2 REVENUE ANALYSIS

28.6.3 GEOGRAPHIC PRESENCE

28.6.4 PRODUCT PORTFOLIO

28.6.5 RECENT DEVELOPMENTS

28.7 ACE MEDICAL DEVICES PVT. LTD

28.7.1 COMPANY OVERVIEW

28.7.2 REVENUE ANALYSIS

28.7.3 GEOGRAPHIC PRESENCE

28.7.4 PRODUCT PORTFOLIO

28.7.5 RECENT DEVELOPMENTS

28.8 MEDTRONIC

28.8.1 COMPANY OVERVIEW

28.8.2 REVENUE ANALYSIS

28.8.3 GEOGRAPHIC PRESENCE

28.8.4 PRODUCT PORTFOLIO

28.8.5 RECENT DEVELOPMENTS

28.9 SPECTRA MEDICAL DEVICES, LLC.

28.9.1 COMPANY OVERVIEW

28.9.2 REVENUE ANALYSIS

28.9.3 GEOGRAPHIC PRESENCE

28.9.4 PRODUCT PORTFOLIO

28.9.5 RECENT DEVELOPMENTS

28.1 MEDORAH MEDITEK PVT. LTD.

28.10.1 COMPANY OVERVIEW

28.10.2 REVENUE ANALYSIS

28.10.3 GEOGRAPHIC PRESENCE

28.10.4 PRODUCT PORTFOLIO

28.10.5 RECENT DEVELOPMENTS

28.11 BEIJING ZKSK TECHNOLOGY CO., LTD.

28.11.1 COMPANY OVERVIEW

28.11.2 REVENUE ANALYSIS

28.11.3 GEOGRAPHIC PRESENCE

28.11.4 PRODUCT PORTFOLIO

28.11.5 RECENT DEVELOPMENTS

28.12 LIMACA-MEDICAL

28.12.1 COMPANY OVERVIEW

28.12.2 REVENUE ANALYSIS

28.12.3 GEOGRAPHIC PRESENCE

28.12.4 PRODUCT PORTFOLIO

28.12.5 RECENT DEVELOPMENTS

28.13 ENDO-MED TECHNOLOGIES PVT. LTD.

28.13.1 COMPANY OVERVIEW

28.13.2 REVENUE ANALYSIS

28.13.3 GEOGRAPHIC PRESENCE

28.13.4 PRODUCT PORTFOLIO

28.13.5 RECENT DEVELOPMENTS

28.14 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO.,LTD

28.14.1 COMPANY OVERVIEW

28.14.2 REVENUE ANALYSIS

28.14.3 GEOGRAPHIC PRESENCE

28.14.4 PRODUCT PORTFOLIO

28.14.5 RECENT DEVELOPMENTS

28.15 HOBBS MEDICAL INC.

28.15.1 COMPANY OVERVIEW

28.15.2 REVENUE ANALYSIS

28.15.3 GEOGRAPHIC PRESENCE

28.15.4 PRODUCT PORTFOLIO

28.15.5 RECENT DEVELOPMENTS

28.16 SHENZHEN MANNERS TECHNOLOGY CO., LTD.

28.16.1 COMPANY OVERVIEW

28.16.2 REVENUE ANALYSIS

28.16.3 GEOGRAPHIC PRESENCE

28.16.4 PRODUCT PORTFOLIO

28.16.5 RECENT DEVELOPMENTS

*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

29 RELATED REPORTS

30 QUESTIONNAIRE

31 CONCLUSION

32 ABOUT DATA BRIDGE MARKET RESEARCH